InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: DoubleJ23 post# 509649

Wednesday, 08/31/2022 12:31:38 PM

Wednesday, August 31, 2022 12:31:38 PM

Post# of 688731
This was in next section:

“Our allogeneic (donor cells) and autologous (patient’s own cells) comprehensive cell therapy manufacturing portfolio of services includes GMP production of cells from a variety of starting materials including immune cell populations (such as T-cells, NKs, Dendritic cells) and stem cells. Our experienced team is well-versed in supporting clients through the development pathway, optimizing development protocols, and securely and swiftly scaling up production from clinical to commercial scale.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News